Gene · 249
Papers3,295
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,295
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Multiomics integration analysis identifies tumor cell-derived MIF as a therapeutic target and potentiates anti-PD-1 therapy in osteosarcoma. | J Immunother Cancer | 2025 | 40846326 | PubTator, text mining | PubMed |
| Genetics and Vitamin D Interactions in Osteoporosis: A Path to Precision Medicine. | J Cell Mol Med | 2025 | 40831018 | PubTator, text mining | PubMed |
| Apelin as a CNS-specific pathway for fenestrated capillary formation in the choroid plexus. | Nat Commun | 2025 | 40830138 | PubTator, text mining | PubMed |
| Evaluation of Low Alkaline Phosphatase Levels in Clinical Practice: Implications for Diagnosing Hypophosphatasia. | Calcif Tissue Int | 2025 | 40828320 | PubTator, text mining | PubMed |
| Epimedium-Derived Exosome-Loaded GelMA Hydrogel Enhances MC3T3-E1 Osteogenesis via PI3K/Akt Pathway. | Cells | 2025 | 40801646 | PubTator, text mining | PubMed |
| Synergistic epigenetic modulation by 5-aza-2'-deoxycytidine and Wnt3a drives osteogenic trans-differentiation of 3T3-L1 pre-adipocytes through Ywhah and Ywhae. | Epigenomics | 2025 | 40792537 | PubTator, text mining | PubMed |
| Osteoblasts sense extracellular levels of phosphate to control the local expression of phosphatases for matrix mineralisation. | Bone Rep | 2025 | 40791815 | PubTator, text mining | PubMed |
| [Delayed bone healing after osteotomy - what the family history revealed]. | Praxis (Bern 1994) | 2025 | 40772747 | PubTator, text mining | PubMed |
| Large-scale plasma proteomics uncovers preclinical molecular signatures of Parkinson's disease and overlap with other neurodegenerative disorders. | medRxiv | 2025 | 40766128 | PubTator, text mining | PubMed |
| Multigenerational genetic inheritance and clinical characteristics of the rare disease hypophosphatasia in 6 families: A case series. | Bone Rep | 2025 | 40746945 | PubTator, text mining | PubMed |
| Hypophosphatasia: A case report. | World J Clin Cases | 2025 | 40726933 | PubTator, text mining | PubMed |
| Hyaluronan-Containing Injectable Magnesium-Calcium Phosphate Cements Demonstrated Improved Performance, Cytocompatibility, and Ability to Support Osteogenic Differentiation In Vitro. | Int J Mol Sci | 2025 | 40724884 | PubTator, text mining | PubMed |
| Clinical characterization and impact of hypophosphatasia in Spain: An observational analysis of the Spanish cohort included in the Global HPP Registry. | Med Clin (Barc) | 2025 | 40714462 | PubTator, text mining | PubMed |
| Comprehensive treatment approaches for skeletal deformities in hypophosphatasia: a case study of ALPL gene variants. | Front Pediatr | 2025 | 40703321 | PubTator, text mining | PubMed |
| Hypophosphatasia in childhood: Diagnosis to management. | Osteoporos Sarcopenia | 2025 | 40677779 | PubTator, text mining | PubMed |
| Biodegradable Piezoelectric Micro- and Nanomaterials for Regenerative Medicine, Targeted Therapy, and Microrobotics. | Small Sci | 2025 | 40657196 | PubTator, text mining | PubMed |
| Generation of a new human iPSC cell line (UOMi010-A) from a patient with hypophosphatasia. | Stem Cell Res | 2025 | 40652798 | PubTator, text mining | PubMed |
| Reprogramming of peripheral blood mononuclear cells from a patient with hypophosphatasia to generate iPSC line (UOMi011-A). | Stem Cell Res | 2025 | 40652797 | PubTator, text mining | PubMed |
| EGR1 Promotes Craniofacial Bone Regeneration via Activation of ALPL⁺PDGFD⁺ Periosteal Stem Cells. | Adv Sci (Weinh) | 2025 | 40650643 | PubTator, text mining | PubMed |
| Hypophosphatasia and neuropathic pain: related to vitamin B6 metabolism? | JBMR Plus | 2025 | 40636590 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/249/papers?page=8